JW Holdings Corporation (KRX:096760)

South Korea · Delayed Price · Currency is KRW

3,805.00

+15.00 (0.40%)

Last updated: Jul 14, 2026, 2:15 PM KST

1.74% (1Y)

Market Cap	263.96B -1.0%
Revenue (ttm)	973.26B +7.6%
Net Income	69.04B +14.4%
EPS	996.59 +17.6%
Shares Out	69.19M
PE Ratio	3.83
Forward PE	n/a
Dividend	155.00 (4.09%)
Ex-Dividend Date	Mar 31, 2026

Volume	105,289
Open	3,770.00
Previous Close	3,790.00
Day's Range	3,705.00 - 3,885.00
52-Week Range	3,145.00 - 4,495.00
Beta	0.57
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About JW Holdings

JW Holdings Corporation, together with its subsidiaries, operates as a healthcare company in South Korea, the United States, Japan, China, and internationally. The company offers amino acid solutions, gastrointestinal agents, wound care, eye care, liver disease treatment, cold medicine, API, oral and topical analgesic, and other miscellaneous pharmaceutical products. It also offers hairdye, hair care, beauty care, and other cosmetics products; infant care system, gynecological examining table, sterilizer equipment, diagnostic imaging equipment,... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1945

Employees 127

Stock Exchange Korea Stock Exchange

Ticker Symbol 096760

Full Company Profile

Financial Performance

In 2025, JW Holdings's revenue was 969.57 billion, an increase of 9.22% compared to the previous year's 887.71 billion. Earnings were 58.50 billion, a decrease of -6.57%.

Financial Statements